Does a Tiny Baby Need More Blood? What Two Big Studies Found

A plain-language guide to the TOP and ETTNO transfusion trials in the smallest premature babies

A question every NICU family eventually faces

If you have spent time beside an incubator in a neonatal intensive care unit (NICU), you may have heard the word transfusion more than once. Babies born very early and very small — under about two pounds, or 1,000 grams — almost always become anemic, meaning they run low on red blood cells. Red cells carry oxygen, so when their numbers fall, doctors often top them up with a small transfusion of donor blood. For decades, one deceptively simple question went unanswered: how low should a baby's blood level be allowed to drop before giving more? In 2020, two large, carefully run studies — one in the United States called TOP [1] and one in Europe called ETTNO [2] — finally gave families and doctors a clear, reassuring answer.

Why these babies get anemic in the first place

Anemia of prematurity is not a disease the baby caught; it is mostly a side effect of being born too soon. A fetus does much of its red-cell building in the final weeks of pregnancy, weeks a premature baby misses. After birth, the tiny body slows its own red-cell production for a while, and the frequent small blood samples needed to monitor a sick newborn add up surprisingly fast. The result is that extremely small babies become the most heavily transfused patients in the entire hospital. Doctors have long tried to reduce this need through gentle measures such as delayed cord clamping and drawing fewer or smaller lab samples [3], but most of these babies still reach a point where a transfusion is considered.

A transfusion itself is a routine, carefully matched procedure: a small, measured amount of donor red blood cells — on the order of a few teaspoons adjusted for the baby's weight — given slowly through an existing line while the baby is closely watched. It is generally very safe. The questions doctors wrestled with were never about whether transfusions work, but about timing: giving one too early might mean exposing a baby to donor blood they did not truly need, while waiting too long might, in theory, deprive a growing brain of oxygen. Finding the right balance is precisely what the two big studies set out to do.

The worry that started it all

For years, many doctors leaned toward giving blood early — keeping levels comfortably high — out of an understandable fear. The brain of a premature baby is growing explosively, and it seemed logical that more oxygen-carrying blood might protect that growth. This instinct was reinforced by an earlier study. A trial known as PINT, published in 2006, compared a "generous" with a "careful" approach to transfusing and found the careful approach did not cause obvious short-term harm [4]. But when the same children were checked again as toddlers, a follow-up analysis hinted that those given less blood might have had slightly more trouble with thinking and learning [5]. That hint was not strong proof — it emerged from a secondary look at the data rather than the main result — but it was frightening enough to change behavior. A major evidence review concluded that giving less blood seemed safe in the short term while honestly admitting that the long-term brain question was unsettled [6]. Many units, not wanting to take chances with a baby's development, drifted toward the more generous approach.

To truly settle the matter, doctors needed studies large enough and long enough to follow these children well past infancy. TOP and ETTNO were built to do exactly that.

What the two studies actually did

Both studies used the fairest method medicine has: they randomly assigned babies to one of two transfusion plans, so that neither the families nor the doctors were choosing based on hunches. One plan used a higher blood-level trigger (transfuse sooner, give more blood); the other used a lower trigger (wait a little longer, give blood only when truly needed). Crucially, the "lower" plan was never about withholding necessary care — both plans were safe, carefully monitored recipes, differing only in timing.

The American TOP study enrolled 1,824 babies across 41 hospitals, with an average birth weight of about 756 grams (roughly a pound and a half) and an average of just under 26 weeks of pregnancy [1]. The European ETTNO study enrolled 1,013 babies, all between 400 and 999 grams, across 36 hospitals, most of them in Germany [2]. Both teams then did the hard, patient work of following the children to about two years of age — checking whether they had survived and how they were developing, including movement, hearing, vision, and thinking skills. The two studies were deliberately different in their fine details, which turns out to be a strength: when two differently designed studies on two continents reach the same conclusion, you can trust that conclusion far more than any single result.

The reassuring answer

Here is the heart of it. Giving more blood did not help. In the American study, the share of babies who died or had a significant developmental difficulty by age two was almost identical between the two plans — about 50.1 percent with the higher-blood approach and 49.8 percent with the lower-blood approach [1]. In the European study, the figures were 44.4 percent versus 42.9 percent — again, no meaningful difference [2]. When researchers looked separately at survival, at cerebral palsy, at hearing and vision, and at thinking and learning, the two approaches came out essentially even on every measure [1][2]. The specific worry that had haunted the field — that giving less blood might quietly harm a child's developing mind — simply did not appear in these much larger, more reliable studies. The earlier signal that had caused so much concern was not confirmed once researchers had enough children to look properly [7].

What did change with the more generous approach was the amount of blood used. Babies on the higher-trigger plan received more transfusions — an average of about six versus four per baby in the American study [1] — and in the European study far more babies needed any transfusion at all (around 81 percent versus 61 percent), with roughly double the total volume of donor blood [2]. So the generous approach exposed each baby to more donors and more procedures, without buying any benefit in survival or development.

What this means for families

For a parent, the practical takeaway is genuinely comforting. If your baby's medical team follows a "careful" or restrictive transfusion plan — waiting until the blood level reaches a sensible lower limit rather than topping up early — they are not cutting corners or taking a risk with your child. They are following what two of the largest and best studies ever done in this area showed to be equally safe [8]. Your baby will still receive a transfusion the moment one is truly needed; the careful plan simply avoids transfusions that the evidence shows make no difference to how your child grows up.

This pattern is not unique to newborns. In older children who are seriously ill, a landmark study called TRIPICU found the same thing years earlier: a lower transfusion trigger was just as safe as a higher one for stable patients [9]. The newborn studies extend that same reassuring lesson to the very smallest patients.

It is also fair to be honest about what the studies did not settle. They compared two specific recipes; they did not prove that an even lower trigger would be fine, and they were not large enough to give a separate, confident answer for the very tiniest or sickest babies, where doctors still rely on careful individual judgment. The studies also followed children to about age two, and researchers would still like to know how these children do at school age. Scientists continue to study how to prevent anemia in the first place and how blood transfusions affect a fragile newborn's body, because there is still more to learn about why these babies struggle and how best to help them [10]. The very earliest follow-up work that first raised the brain question used sensitive testing methods whose later, larger results did not bear out the original worry [11].

Questions you can ask the care team

If your family wants to understand your own baby's care, a few gentle questions can help: What transfusion plan does this unit follow, and what blood level triggers a transfusion? Is my baby being transfused because of a number, or because of how they are doing clinically? What are you doing to reduce how much blood is drawn for tests? Care teams generally welcome these questions, and the existence of clear, modern guidelines built on these trials means they can give you concrete answers [12].

The bottom line

Two large studies, on two continents, using two slightly different designs, arrived at the same conclusion: for extremely small premature babies, giving more blood does not improve survival or development, and a careful, lower-threshold approach is safe. That is an unusually clean and hopeful result in newborn medicine. It means fewer unnecessary transfusions, fewer donor exposures, and — most importantly — no hidden cost to your child's future. If your baby's team is practicing this way, they are practicing good, evidence-based medicine, and that is something a worried family can take real comfort in.

References

  1. Kirpalani H, Bell EF, Hintz SR, et al; Eunice Kennedy Shriver NICHD Neonatal Research Network. Higher or lower hemoglobin transfusion thresholds for preterm infants. N Engl J Med. 2020;383(27):2639–2651. doi:10.1056/NEJMoa2020248 ↩
  2. Franz AR, Engel C, Bassler D, et al; ETTNO Investigators. Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants: the ETTNO randomized clinical trial. JAMA. 2020;324(6):560–570. doi:10.1001/jama.2020.10690 ↩
  3. Goel R, Josephson CD. Recent advances in transfusions in neonates/infants. F1000Res. 2018;7. doi:10.12688/f1000research.13979.1 ↩
  4. Kirpalani H, Whyte RK, Andersen C, et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006;149(3):301–307. doi:10.1016/j.jpeds.2006.05.011 ↩
  5. Whyte RK, Kirpalani H, Asztalos EV, et al; PINTOS Study Group. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics. 2009;123(1):207–213. doi:10.1542/peds.2008-0338 ↩
  6. Whyte RK, Kirpalani H. Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants. Cochrane Database Syst Rev. 2011;(11):CD000512. doi:10.1002/14651858.CD000512.pub2 ↩
  7. Bell EF. Red cell transfusion thresholds for preterm infants: finally some answers. Arch Dis Child Fetal Neonatal Ed. Published online 2021. doi:10.1136/archdischild-2020-320495 ↩
  8. Meyer MP, O'Connor KL, Meyer JH. Thresholds for blood transfusion in extremely preterm infants: a review of the latest evidence from two large clinical trials. Front Pediatr. 2022;10:957585. doi:10.3389/fped.2022.957585 ↩
  9. Lacroix J, Hébert PC, Hutchison JS, et al; TRIPICU Investigators. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356(16):1609–1619. doi:10.1056/NEJMoa066240 ↩
  10. Patel RM, Meyer EK, Widness JA. Research opportunities to improve neonatal red blood cell transfusion. Transfus Med Rev. 2016;30(4):165–173. doi:10.1016/j.tmrv.2016.06.005 ↩
  11. McCoy TE, Conrad AL, Richman LC, et al. Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion. Child Neuropsychol. 2011;17:347–367. doi:10.1080/09297049.2010.544647 ↩
  12. Franz AR, Engel C, Bassler D, et al. The 'Effects of Transfusion Thresholds on Neurocognitive Outcome of extremely low birth-weight infants (ETTNO)' study: background, aims, and study protocol. Neonatology. 2012;101(4):301–305. doi:10.1159/000335030 ↩